The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 261 through 270 of 353 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

COVID-19 Variant Supplement – Development of safe and effective vaccines against COVID-19

Liu, Jun | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

Biomarker Discovery for the Post-COVID Pulmonary Syndrome

Sin, Donald | University of British Columbia | Operating Grant | $499,500

CIHR British Columbia 2021

Vaccine Outreach Integrating Community Engagement & Science (VOICES): Addressing COVID‑19 Vaccine Hesitancy and Promoting Uptake among Racialized Sexual and Gender Minority Populations

Newman, Peter A | University of Toronto | Operating Grant | $374,314

CIHR Ontario 2021

COVID-19 Variant Supplement – Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Langlois, Marc-Andre | University of Ottawa | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Understanding the pathogenesis of COVID-19

Flamand, Louis | CHU de Québec | Operating Grant | $50,000

CIHR Quebec 2021

Teasing apart the differential impact of variants of concern on COVID‑19 severity and health inequities: a population-based genomic epidemiological investigation in Ontario and British Columbia.

Sbihi, Hind | B.C. Centre for Disease Control | Operating Grant | $451,188

CIHR British Columbia 2021

COVID-19 Variant Supplement – Expression and Purification of COVID19 Virus Spike (S) Protein for Diagnostics and Vaccines

Richardson, Christopher D | Dalhousie University | Operating Grant | $50,000

CIHR Nova Scotia 2021

Variations on a theme: New approaches to examine SARS-CoV-2 variants and their ABO connections

West, Lori J | University of Alberta | Operating Grant | $482,935

CIHR Alberta 2021

COVID-19 Variant Supplement – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

Lemieux, Joanne M | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

COVID-19 Variant Supplement – Development of safe and effective vaccines against COVID-19

Biomarker Discovery for the Post-COVID Pulmonary Syndrome

Vaccine Outreach Integrating Community Engagement & Science (VOICES): Addressing COVID‑19 Vaccine Hesitancy and Promoting Uptake among Racialized Sexual and Gender Minority Populations

COVID-19 Variant Supplement – Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

COVID-19 Variant Supplement – Understanding the pathogenesis of COVID-19

Teasing apart the differential impact of variants of concern on COVID‑19 severity and health inequities: a population-based genomic epidemiological investigation in Ontario and British Columbia.

COVID-19 Variant Supplement – Expression and Purification of COVID19 Virus Spike (S) Protein for Diagnostics and Vaccines

Variations on a theme: New approaches to examine SARS-CoV-2 variants and their ABO connections

COVID-19 Variant Supplement – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment